AstraZeneca (LSE:AZN) recently launched "FluMist Home," an at-home flu vaccine delivery service, marking an important ...

AstraZeneca PLC thrives with $54B revenue and 14 blockbusters in 2024, fueled by oncology and rare disease growth. Click for ...

AstraZeneca is making flu protection more convenient with the launch of an at-home delivery option for FluMist, its nasal spray flu vaccine, the company announced Friday. On the market since 2003, ...

AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration — though much of what it is ...

FluMist has been approved since 2003, but, until last year, only for administration by a healthcare practitioner. The new nod ...

He said about Britain that the firm needed “to see that there is access and a reason to invest.” This is partly a negotiating ...

The UK’s National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for AstraZeneca’s ...

AstraZeneca Vietnam has been recognised as one of the “Best Companies to Work for in Asia 2025” by HR Asia, underscoring its ...